The Israeli government press office and the Israeli Ministry of Health issued a statement on the 6th saying that the country’s research shows that the fourth dose of the new crown vaccine can improve the protection effect of severe disease by about 3 times for people aged 60 and over.

The study is based on data from more than 1 million Israelis aged 60 and older who were eligible for the fourth dose of the Covid-19 vaccine between Jan. 10 and March 2, the

statement said. , the research team analyzed the effectiveness of the fourth dose of the vaccine. The research was carried out by the Weizmann Institute of Science, the Israeli Ministry of Health and other institutions and has been published in the New England Journal of Medicine in the United States.

Study found that people 60 and older who received a fourth dose of Pfizer’s COVID-19 vaccine had a reduced risk of severe illness compared to those 60 and older who received only 3 doses of Pfizer’s COVID-19 vaccine about two-thirds, and the protective effect did not diminish throughout the study period; the risk of being diagnosed with the new coronavirus was reduced by about half, but the protective effect diminished during the 8-week study period.

At present, the Israeli Ministry of Health stipulates that people aged 60 and above, medical workers and other high-risk groups can receive the fourth dose of the new crown vaccine, and the vaccination time must be separated from the third dose At least 4 months.

According to the epidemic data released by the Ministry of Health on the 5th, there were 10,689 new confirmed cases of the new crown in the country in the past 24 hours, with a total of more than 3.96 million confirmed cases and a total of 10,554 deaths. . Of the country’s population of about 9.45 million, about 6.7 million people have received at least one dose of the new crown vaccine, about 6.13 million people have received two doses, about 4.48 million people have received a third dose of the vaccine, and about 770,000 people have received a fourth dose of the vaccine .